New Type 2 Drugs Change Treatment Decisions
Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of
Read moreMetformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of
Read moreInsulin sensitizers–drugs that increase sensitivity to insulin such as Avandia and Actos–could help lessen the risk of peripheral arterial disease
Read moreA significant majority-20 of 26 members attending a combined meeting of FDA advisory committees-has voted to modify or remove the
Read moreThe Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type
Read more